MoneyWorks4Me

Sun Pharmaceutical Industries informs about update

27 May 2023 Evaluate

In connection with its earnings call held on May 26, 2023, Sun Pharmaceutical Industries has informed that Global Ilumya sales for FY23 were US$ 477 million, up by about 51% as compared to FY22.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..